« Vivus, Qnexa, Arena, Lorcaserin and the FDA |
| Biosimilars: Not Easy, But Not Impossible, Either »
July 23, 2010
Aventis: Is It Genzyme?
Genzyme's stock has jumped straight up this afternoon, and word is that they're the target of the rumored Sanofi-Aventis takeover move. This is being attributed to "people with knowledge of the matter", which is generally shorthand for "people that we know are highly placed insiders but that we've agreed not to name".
You have to think that if GENZ hadn't had their manufacturing woes that this wouldn't be happening.
+ TrackBacks (0) | Category: Business and Markets
POST A COMMENT
- RELATED ENTRIES
- How Not to Do It: NMR Magnets
- Allergan Escapes Valeant
- Vytorin Actually Works
- Fatalities at DuPont
- The New York TImes on Drug Discovery
- How Are Things at Princeton?
- Phage-Derived Catalysts
- Our Most Snorted-At Papers This Month. . .